What is Hy2Care?
Hy2Care, a spin-off from the MIRA Institute at the University of Twente, Netherlands, is at the forefront of biomedical and chemical engineering. Since 2007, the company has channeled over 4 million EURO into developing a proprietary platform technology, evidenced by three granted patents in Europe and the US, with further intellectual property filings underway. Product prototyping and initial animal testing have been successfully completed. Market studies and direct engagement with key opinion leaders in orthopedic surgery have confirmed substantial interest from internationally recognized surgeons eager to integrate Hy2Care's products into their daily practice, positioning the company for significant market penetration in the orthopedic device sector.
How much funding has Hy2Care raised?
Hy2Care has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2025): $5M with participation from Brightlands Venture Partners, The European Innovation Council, and Liof
Key Investors in Hy2Care
Brightlands Venture Partners
Brightlands Venture Partners (BVP) is an investment firm focused on innovative companies addressing global challenges in health, agrifood, and renewable chemistry. They actively support outlier founders from Seed to Series A stages, primarily in Europe, with investments ranging from 250k to 2M.
The European Innovation Council
The European Innovation Council operates within the higher education sector, focusing on fostering innovation and technological advancement across Europe.
Liof
LIOF is the regional development agency for Limburg, supporting entrepreneurs through advice, networking, and financing to foster innovation, investment, and internationalization within the region.
What's next for Hy2Care?
This major enterprise-level funding marks a pivotal moment for Hy2Care, signaling a transition from development to a scaling phase. The substantial capital injection is expected to accelerate product commercialization, expand market reach, and further bolster research and development efforts. Strategic partnerships and continued innovation will be key as Hy2Care aims to solidify its position as a leader in orthopedic solutions, leveraging its advanced platform technology to address unmet clinical needs and drive advancements in patient care.
See full Hy2Care company page
